Zymosense, a leader in enzyme assay innovation, today announced the launch of the Nanoassaytm, an innovation that redefines enzyme measurement by harnessing the unique properties of single-walled ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 ...
Quantumzyme Corp. (OTCQB: QTZM), a biotechnology company pioneering enzyme engineering and green chemistry solutions, is pleased to announce details regarding the World Intellectual Property ...
New England Biolabs (NEB®), a global leader in enzyme technologies and molecular biology solutions, will highlight its latest advances in molecular diagnostics and infectious disease surveillance at ...
Cellexia's Cellular Renewal Cream takes a fundamentally different approach. Instead of just smoothing existing wrinkles or ...
A new study has identified a key enzyme that modulates tea plant immunity by regulating salicylic acid (SA), a critical plant defense hormone. The enzyme, CsUGT74B5, catalyzes the conversion of SA ...
Doxorubicin (DOX) is widely used to treat cancer but can cause severe heart damage. In a recent study, researchers from China ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
Hansa Biopharma AB ( ($SE:HNSA) ) has issued an update. Hansa Biopharma announced that its drug imlifidase successfully met the primary endpoint ...
The 16th World ADC San Diego, held from November 3-6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback